646 related articles for article (PubMed ID: 30232187)
1. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
[TBL] [Abstract][Full Text] [Related]
2. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus fails to activate NF-κB signaling in plasmacytoid dendritic cells.
Dental C; Florentin J; Aouar B; Gondois-Rey F; Durantel D; Baumert TF; Nunes JA; Olive D; Hirsch I; Stranska R
J Virol; 2012 Jan; 86(2):1090-6. PubMed ID: 22090103
[TBL] [Abstract][Full Text] [Related]
4. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells.
Grabski E; Wappler I; Pfaender S; Steinmann E; Haid S; Dzionek A; Pietschmann T; Kalinke U
J Virol; 2015 Mar; 89(6):3200-8. PubMed ID: 25552725
[TBL] [Abstract][Full Text] [Related]
5. HCV glycoprotein E2 is a novel BDCA-2 ligand and acts as an inhibitor of IFN production by plasmacytoid dendritic cells.
Florentin J; Aouar B; Dental C; Thumann C; Firaguay G; Gondois-Rey F; Soumelis V; Baumert TF; Nunès JA; Olive D; Hirsch I; Stranska R
Blood; 2012 Nov; 120(23):4544-51. PubMed ID: 23053572
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.
Dolganiuc A; Chang S; Kodys K; Mandrekar P; Bakis G; Cormier M; Szabo G
J Immunol; 2006 Nov; 177(10):6758-68. PubMed ID: 17082589
[TBL] [Abstract][Full Text] [Related]
7. A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.
Libri NA; Barker SJ; Rosenberg WM; Semper AE
J Viral Hepat; 2009 May; 16(5):315-24. PubMed ID: 19243499
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
Zhang S; Saha B; Kodys K; Szabo G
J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1.
Gondois-Rey F; Dental C; Halfon P; Baumert TF; Olive D; Hirsch I
PLoS One; 2009; 4(2):e4319. PubMed ID: 19183807
[TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
Sacre K; Criswell LA; McCune JM
Arthritis Res Ther; 2012 Jun; 14(3):R155. PubMed ID: 22734582
[TBL] [Abstract][Full Text] [Related]
12. HMGB1 Is Involved in IFN-α Production and TRAIL Expression by HIV-1-Exposed Plasmacytoid Dendritic Cells: Impact of the Crosstalk with NK Cells.
Saïdi H; Bras M; Formaglio P; Melki MT; Charbit B; Herbeuval JP; Gougeon ML
PLoS Pathog; 2016 Feb; 12(2):e1005407. PubMed ID: 26871575
[TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus-1 Impairs IFN-Alpha Production Induced by TLR-7 Agonist in Plasmacytoid Dendritic Cells.
Dhamanage A; Thakar M; Paranjape R
Viral Immunol; 2017; 30(1):28-34. PubMed ID: 27809682
[TBL] [Abstract][Full Text] [Related]
14. TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-α-mediated antitumor reactivity.
Kalb ML; Glaser A; Stary G; Koszik F; Stingl G
J Immunol; 2012 Feb; 188(4):1583-91. PubMed ID: 22231699
[TBL] [Abstract][Full Text] [Related]
15. Prednisolone does not affect direct-acting antivirals against hepatitis C, but inhibits interferon-alpha production by plasmacytoid dendritic cells.
de Ruiter PE; Boor PP; de Jonge J; Metselaar HJ; Tilanus HW; Ijzermans JN; Kwekkeboom J; van der Laan LJ
Transpl Infect Dis; 2015 Oct; 17(5):707-15. PubMed ID: 26250892
[TBL] [Abstract][Full Text] [Related]
16. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cell number and responses to Toll-like receptor 7 and 9 agonists vary in HIV Type 1-infected individuals in relation to clinical state.
Kaushik S; Teque F; Patel M; Fujimura SH; Schmidt B; Levy JA
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):501-10. PubMed ID: 23131038
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin Contributes to Hepatitis C Virus Suppression by Augmenting pDC Activation and Type 1 IFN Production.
Wang Y; McGivern DR; Cheng L; Li G; Lemon SM; Niu J; Su L; Reszka-Blanco NJ
PLoS One; 2015; 10(8):e0135232. PubMed ID: 26274905
[TBL] [Abstract][Full Text] [Related]
19. TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.
Yonkers NL; Rodriguez B; Milkovich KA; Asaad R; Lederman MM; Heeger PS; Anthony DD
J Immunol; 2007 Apr; 178(7):4436-44. PubMed ID: 17372001
[TBL] [Abstract][Full Text] [Related]
20. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
Gujer C; Sundling C; Seder RA; Karlsson Hedestam GB; Loré K
Immunology; 2011 Nov; 134(3):257-69. PubMed ID: 21977996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
